Hjem › Ikke-muskulinvasiv blærecancer › Arizona
Kliniske studier for Ikke-muskulinvasiv blærecancer i Arizona
9 studier for Ikke-muskulinvasiv blærecancer søker deltakere på steder i Arizona.
Byer i Arizona
Offisiell studietekst (engelsk)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Banner MD Anderson Cancer Center, Gilbert
- Mayo Clinic Hospital in Arizona, Phoenix
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07000084A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Academic Urology and Urogynecology of Arizona, Sun City
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06919965Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Mayo Clinic, Phoenix
- East Valley Urology Center of Arizona, Queen Creek
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05951179Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- East Valley Urology Center of Arizona, Queen Creek
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 21. aug. 2026 · NCT07480356FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- University of Arizona - Cancer Center, Tucson
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT05614739LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Mayo Clinic, Scottsdale
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT04752722A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
- East Valley Urology Center of Arizona, Mesa
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 27. mai 2026 · NCT05710848ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
- Arizona Clinical Trials, Chandler
RekruttererFase 1/2
Alder 18 til 85 · Alle kjønn · Oppdatert 27. mar. 2026 · NCT06800963Blue Light Cystoscopy With Cysview® Registry
- Mayo Clinic, Phoenix
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 18. des. 2025 · NCT02660645Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.